Compounds > bisindolylmaleimide i
Page last updated: 2024-10-23

bisindolylmaleimide i and Pancreatitis, Chronic

bisindolylmaleimide i has been researched along with Pancreatitis, Chronic in 1 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Pancreatitis, Chronic: INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, M1
Shibahara, J1
Fukushima, N1
Shinozaki, A1
Umeda, M1
Ishikawa, S1
Kokudo, N1
Fukayama, M1

Other Studies

1 other study available for bisindolylmaleimide i and Pancreatitis, Chronic

ArticleYear
Claudin-18 is an early-stage marker of pancreatic carcinogenesis.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2011, Volume: 59, Issue:10

    Topics: Adenocarcinoma, Mucinous; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Cel

2011